Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults
Disease area: Paediatric lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
J-P. Zellweger (Villars-Sur-Glâne, Switzerland). Challenges in TB treatment in adults. International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults

Member's Comments

No comment yet.

Related content which might interest you: Challenges in TB treatment in children Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults Year: 2014 Challenges in the prevention, diagnosis, and treatment of tuberculosis in children Source: International Congress 2019 – Tuberculosis: latest advances and challenges in patient management Year: 2019 Effectiveness of treatment for MDR TB in children and adolescents Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases Year: 2007 Identification and clinical management of LTBI in children versus adults Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults Year: 2014 Preventive chemotherapy effectiveness in children and adolescents, contacting TB patients with DR TB strains Source: Eur Respir J 2006; 28: Suppl. 50, 536s Year: 2006 Implementing interventions to prevent and manage TB in both children and adults Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults Year: 2014 New approaches to MDR/XDR TB chemotherapy in children and adolescents Source: International Congress 2019 – Tuberculosis: treatment and management Year: 2019 Treatment outcomes of new TB cases among children in Russia Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 Prospects for early implementation of ambulatory treatment in XDR TB patients by optimizing the administration of linezolid at the intensive phase of chemotherapy Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 Challenges in childhood tuberculosis Source: Eur Respir Monogr 2018; 82: 234-262 Year: 2018 Impact of social support programme on MDR-TB patients' treatment outcomes Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3 Year: 2014 Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of multidrug-resistant tuberculosis Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016 New approaches for evaluation of treatment effectiveness among patients with pulmonary TB under DOTS implemented conditions Source: Eur Respir J 2002; 20: Suppl. 38, 368s Year: 2002 Predictors of defaulting from treatment among patients with tuberculosis Source: International Congress 2015 – Management of TB: a patient focus Year: 2015 Bedaquiline-containing regimens for MDR TB treatment – Focus on the safety Source: International Congress 2016 – Drug-resistant tuberculosis and experiences with delamanid and bedaquiline Year: 2016 Approaches to TB prediction in patients with COPD Source: Virtual Congress 2021 – Health effects of tobacco and medical professionals Year: 2021 MDR-TB treatment outcomes in HIV positive patients Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014 Managing adult and children XDR-TB cases with limited clinical options Source: International Congress 2018 – CC4 Tuberculosis Year: 2018 Adolescents and young adults: a neglected population group for tuberculosis surveillance Source: Eur Respir J, 51 (2) 1800176; 10.1183/13993003.00176-2018 Year: 2018